Leslie Chong
CEO and Managing Director of Imugene, a biotech company developing CAR-T cancer therapies, with decades of experience in cancer drug development and multiple drugs shepherded through development.
Best podcasts with Leslie Chong
Ranked by the Snipd community
Feb 25, 2026 • 12min
Q+A: How this biotech CEO keeps the faith in a cancer cure
Leslie Chong, CEO and Managing Director of Imugene with decades in cancer drug development. She discusses why she stays committed to long biotech timelines. She names azur‑cel as the lead CAR‑T prospect and explains its off‑the‑shelf donor approach. She covers trial stages, FDA feedback, fast‑to‑market niche strategies, and choices between partnering or commercialising alone.
